IVC Evidensia explores sale

EQT-backed IVC Evidensia is reportedly planning an initial public offering in London and has appointed Goldman Sachs and Jefferies for an up-to £10bn listing that could take place early next year. This would put the European vet group straight into the FTSE100 list. EQT acquired Evidensia in 2014. Two years later it acquired Independent Vetcare…

You must be a HMI Subscriber to view this content.

Subscribe Now »